Biogen Inc. (NASDAQ:BIIB – Free Report) – Stock analysts at Leerink Partnrs lifted their FY2023 earnings estimates for Biogen in a research report issued on Sunday, October 8th. Leerink Partnrs analyst M. Goodman now forecasts that the biotechnology company will post earnings of $15.75 per share for the year, up from their prior estimate of […]
Arlington Partners LLC reduced its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 1.0% during the second quarter, HoldingsChannel.com reports. The fund owned 5,025 shares of the biotechnology company’s stock after selling 50 shares during the quarter. Arlington Partners LLC’s holdings in Biogen were worth $1,431,000 as of its most recent filing […]
DekaBank Deutsche Girozentrale increased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 1.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 238,599 shares of the biotechnology company’s stock after acquiring an additional 4,317 shares during […]
Biogen (NASDAQ:BIIB – Free Report) had its price target boosted by Morgan Stanley from $363.00 to $381.00 in a report published on Tuesday, MarketBeat reports. They currently have an overweight rating on the biotechnology company’s stock. A number of other analysts also recently commented on BIIB. Argus boosted their target price on shares of Biogen […]
Gitterman Wealth Management LLC purchased a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 893 shares of the biotechnology company’s stock, valued at approximately $248,000. A number of other hedge funds have also recently […]